New Juvenile Idiopathic Arthritis Guideline Emphasizes Disease-Modifying Treatments, Urges Immunizations

The American College of Rheumatology (ACR) will preview a new clinical practice guideline for the management of juvenile idiopathic arthritis (JIA) at ACR Convergence, the ACR’s annual meeting. The new recommendations include treatments for systemic JIA, oligoarthritis, TMJ arthritis, and recommendations for medication monitoring and immunizations.